1. Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales
- Author
-
Siripat Chaichit, Huiqing Yu, Takuto Sato, Takamasa Mizoguchi, Motoyuki Itoh, Yu-ki Tanaka, and Yasumitsu Ogra
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Pharmaceutical Science ,030209 endocrinology & metabolism ,cathepsin K ,Bone resorption ,Article ,scale ,03 medical and health sciences ,Pharmacy and materia medica ,0302 clinical medicine ,Osteoclast ,Internal medicine ,Drug Discovery ,medicine ,Cathepsin K ,Dexamethasone ,Tartrate-resistant acid phosphatase ,biology ,Chemistry ,Acid phosphatase ,glucocorticoid-induced osteoporosis ,zebrafish ,RS1-441 ,030104 developmental biology ,Endocrinology ,medicine.anatomical_structure ,biology.protein ,Medicine ,Molecular Medicine ,Alkaline phosphatase ,Secondary osteoporosis ,tartrate-resistant acid phosphatase ,alkaline phosphatase ,medicine.drug - Abstract
Glucocorticoid-induced osteoporosis (GIOP) is a major cause of secondary osteoporosis, and the pathogenic mechanisms of GIOP remain to be elucidated. Here, we show a rapid dexamethasone-induced osteoporosis animal model using zebrafish scales. Intraperitoneal injection of dexamethasone over a 5-day period suppressed the regeneration of scales. Furthermore, the circularity of the newly formed regenerated scales was also slightly reduced compared to that of the control group on day 5. The changes in bone-related enzymes, such as cathepsin K, tartrate-resistant acid phosphatase (TRAP) for bone resorption, and alkaline phosphatase (ALP) for bone formation, provide insight into the progression of bone diseases, therefore, we further developed a method to measure the activities of cathepsin K, TRAP, and ALP using zebrafish scales. We found that a lysis buffer with detergent at neutral pH under sonication efficiently helped extract these three enzymes with high activity levels. Interestingly, treatment with a dexamethasone injection produced considerably higher levels of cathepsin K activity and a lower Ca/P ratio than those in the control group, suggesting that dexamethasone increased osteoclast activity, with no significant changes in the activities of TRAP and ALP. Our GIOP model and enzyme assay method could help to design better treatments for GIOP.
- Published
- 2021